Hypercalcæmi blev rapporteret hos 25, 3% og hypercalcuri forekom hos 39, 3% af de patienter, der var i Preotactbehandling.
Hypercalcemia was reported in 25.3% of patients and hypercalciuria in 39.3% of patients treated with Preotact.